Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort
Authors:
Top Cited Papers
Open Access
- 13 March 2024
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 403 (10433) , 1279-1289
Abstract
No abstract availableKeywords
Funding Information
- Polycystic Kidney Disease Charity
- UKRI Medical Research Council
- Kidney Research UK
This publication has 21 references indexed in Scilit:
- Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trialThe Lancet, 2023
- The Orphan Drug Act RevisitedJAMA, 2019
- The European Union Policy in the Field of Rare Diseases2017
- Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2017
- Chronic Kidney DiseaseThe Lancet, 2017
- Rare inherited kidney diseases: challenges, opportunities, and perspectivesThe Lancet, 2014
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Unreferred chronic kidney disease: a longitudinal studyAmerican Journal of Kidney Diseases, 2004
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999